Deutsche Bank AG Sells 331 Shares of Encompass Health Corporation $EHC

Deutsche Bank AG cut its holdings in Encompass Health Corporation (NYSE:EHC) by 3.4% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 9,483 shares of the company’s stock after selling 331 shares during the quarter. Deutsche Bank AG’s holdings in Encompass Health were worth $960,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. OneDigital Investment Advisors LLC acquired a new stake in Encompass Health during the 1st quarter worth approximately $263,000. GAMMA Investing LLC raised its holdings in shares of Encompass Health by 21.5% during the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company’s stock worth $240,000 after acquiring an additional 419 shares during the period. Sequoia Financial Advisors LLC lifted its position in Encompass Health by 6.7% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company’s stock valued at $276,000 after acquiring an additional 172 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its position in Encompass Health by 30.1% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company’s stock valued at $972,000 after acquiring an additional 2,218 shares in the last quarter. Finally, Fifth Third Bancorp boosted its stake in Encompass Health by 88.7% in the 1st quarter. Fifth Third Bancorp now owns 4,290 shares of the company’s stock worth $434,000 after purchasing an additional 2,017 shares during the period. 97.25% of the stock is owned by institutional investors.

Encompass Health Price Performance

Shares of EHC opened at $122.76 on Monday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The company’s fifty day simple moving average is $116.38 and its 200 day simple moving average is $110.41. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $124.67. The company has a market cap of $12.36 billion, a price-to-earnings ratio of 24.02, a PEG ratio of 2.15 and a beta of 0.86.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The firm had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter last year, the company posted $1.11 earnings per share. The company’s revenue for the quarter was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, research analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. The ex-dividend date is Wednesday, October 1st. This is an increase from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Encompass Health’s dividend payout ratio is 13.31%.

Wall Street Analyst Weigh In

EHC has been the topic of several recent research reports. Royal Bank Of Canada lifted their price target on Encompass Health from $110.00 to $125.00 and gave the company an “outperform” rating in a research note on Monday, April 28th. UBS Group lifted their target price on Encompass Health from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. Truist Financial upped their price target on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research report on Thursday, August 14th. Wall Street Zen cut shares of Encompass Health from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 6th. Finally, KeyCorp boosted their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $134.00.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.